Alana Hippensteele, Editor

New research on the structure of HIV has revealed a promising novel drug target for treating HIV infection.

In a lecture at the virtual Community Oncology Conference 2020, Christine Roussel discussed some clinical considerations for the use of medical cannabis in patients with cancer.

A study recently investigated uterine serous carcinoma in order to more quickly identify those patients with an advanced form of the disease and find the appropriate treatment method for them.

Pharmacist Moms Group founder Suzanne Soliman, PharmD, BCMAS, speaks on the power of social media in the field of pharmacy in the age of COVID-19.

An expert panel at the Community Oncology Conference 2020 discussed how COVID-19 is changing the future of community oncology.

A new study showed that most women living with HIV that were interviewed preferred long-acting injectable adherence to antiretroviral therapy over daily pills.

A new study indicates that treatment with hydroxychloroquine increases overall mortality in patients hospitalized with COVID-19.

Using CRISPR technology, researchers conducted a study aimed at identifying genes that fuel leukemia growth, in order to find new vulnerabilities in chronic myeloid leukemia that can be targeted.

In preliminary data from the trial evaluating dostarlimab, the results demonstrated that the clinical activity in patients with previously treated recurrent or advanced mismatch repair (MMR)-deficient endometrial cancer had an acceptable safety profile.

The new expanded approval was based on positive results from the phase 3 E1912 study.

Treatment of ovarian cancer with poly (ADP-ribose) polymerase (PARP) inhibitors has a high out-of-pocket cost for patients, with substantial variation among them, according to a study.

Obesity increases the risk of developing type 2 diabetes by at least 6 times, regardless of genetic predisposition, according to a recent study.

A phase 3 trial evaluated nivolumab in combination with ipilimumab in patients with previously untreated MPM and successfully met its primary endpoint of overall survival.

The phase 3 trial evaluating nivolumab in combination with cabozantinib demonstrated positive results in the treatment of renal cell carcinoma (RCC).

A new study revealed that researchers have found a genetic test that could help doctors determine which patients with multiple myeloma are at “ultra high risk” of their cancer progressing aggressively in its early stages.

A new study found that alternative swab materials and commonly available saline are effective for COVID-19 testing, allowing patients to self-administer tests.

The CDC's updated guidance for pharmacies during the COVID-19 pandemic is based on the most recent information regarding safety practices and precautions for the disease.

In a new study, researchers present their findings of a signaling pathway that could be used in patients with triple-negative breast cancer (TNBC) to enhance therapies in the future.

The antiviral drug remdesivir has been shown by researchers to effectively stop the replication mechanism of SARS-CoV-2 that causes COVID-19, according to a new study.

A new study investigated the molecular impact of the cancer-killing PARP-1 inhibitor (PARPi) binding to PARP-1 and found that the drug can be structurally modified to increase its power to kill tumor cells.

Vaccine skepticism, or a hesitancy or unwillingness to get vaccinated or to vaccinate one’s children, may be the result of some people overestimating the likelihood of negative events.

Researchers investigated the presence of coronaviruses in the bat population due to an understanding that coronaviruses can spread following a spillover from animals.

Chloroquine, hydroxychloroquine, and azithromycin are currently being evaluated as potential treatments for COVID-19, despite limited evidence to support the drugs’ efficacy.

Researchers presented findings in conjunction with the Society of Gynecologic Oncology 2020 Annual Meeting on Women’s Cancer on the phase 3 VELIA trial studying the safety of veliparib.

The kinase inhibitor selumetinib was approved for the treatment of pediatric patients aged 2 years and older with neurofibromatosis type 1 who have symptomatic, inoperable plexiform neurofibromas.

Providers with access to COVID-19 tests have reported false-negative results for some patients, raising concerns about the limitations of tests as a source of reliable information.

Pain is the most common reason patients seek medical marijuana, yet patients' resulting consumption patterns of marijuana when treating pain may also have an effect on their health.

There have been reports of patients with COVID-19 having ST-segment elevation (STE) and, even after invasive coronary angiography, continuing to show no signs of COVID-19.

COA released a statement explaining that it fundamentally opposes home infusion of chemotherapy, cancer immunotherapy, and cancer treatment supportive drugs due to concerns regarding the safety of patients in such an environment.